1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Key Pharma News 06 JULY 2015

Key Pharma News 06 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 35 pages

Industry Trend Analysis - Continuous Manufacturing Represents Future Of Pharmaceutical Production
Industry Trend Analysis - Increased CAR-T Investment View Playing Out
Industry Brief - Provectus/Boehringer Collaborate To Bring PV-10 Into China
Industry Brief - Actavis Name Change To Allergan Takes Effect
Industry Brief - Allergan To Acquire Kythera Biopharmaceuticals
Industry Brief - GSK Consumer Healthcare Announces New US HQ Location
Industry Brief - Novartis To Acquire Spinifex Pharmaceuticals
Industry Brief - Teva Completes Purchase Of 4.61% Interest In Mylan
Industry Trend Analysis - TAF To Keep Gilead At Top Of HIV Market
Industry Trend Analysis - Cost Will Impact Perjeta's Success In Europe
Industry Brief - Humira Receives Positive CHMP Opinion For Hidradenitis Suppurativa
Industry Brief - UCB Submits Lacosamide In Japan For Epilepsy
Industry Trend Analysis - Lilly Alimta Appeal Win To Push Back Generic Competition
Industry Brief - GSK Sells Legacy Meningitis Vaccines To Pfizer
Industry Brief - Gilead's Harvoni Approved In Japan
Industry Trend Analysis - Cancer Drug Pricing To Remain In Firing Line
Industry Brief - The Medicines Company's Kengreal Approved In US
Industry Trend Analysis - Anti-PD-1 Battle To Intensify In Europe
Industry Trend Analysis - Gardasil 9 To Keep Merck On Top Of HPV Market
Industry Brief - Novo Nordisk To Cease Tresiba's Distribution In Germany
Industry Trend Analysis - Copaxone 20mg's US Sales To Drop At Least 80%
Industry Brief - FDA Extends Review Period For Cariprazine To September
Industry Trend Analysis - Additional Indication Will Strengthen Promacta's Position As A Niche Drug
Industry Brief - Invega Trinza Available In US
Industry Brief - MPP And Gilead Expand TAF And TDF Licenses To South Africa
Industry Trend Analysis - Vyvanse Sales To Continue Rising
Industry Brief - FDA Approves Eisai's Fycompa As Adjunctive Treatment For PGTC Seizures
Industry Brief - Daiichi Sankyo's Lixiana Approved In EU
Industry Brief - FDA Accepts Teva's Reslizumab BLA For Review
Industry Trend Analysis - Interchangeability Guidance Will Be Essential For US Biosimilar Market To Flourish
Industry Brief - Simponi Receives EC Approval For Nr-Axial SpA
Industry Brief - Levemir Receives Positive CHMP Opinion For Use In Children As Young As One
Industry Brief - Eisai's Fycompa Gains EC Marketing Authorisation For PGTC Seizures
Industry Brief - CHMP Adopts Positive Opinion On Novartis' Farydak For MM
Industry Trend Analysis - Clovis Still Faces AstraZeneca Threat After Filing First
Industry Trend Analysis - Gilead To Maintain Position Despite Impressive Rival Cure Rates In HCV Subpopulations
Industry Trend Analysis - Growing Market And Unmet Needs Will Drive Neuroscience R&D
Industry Brief - Vectibix Significantly Improves OS Versus Supportive Care In Phase III MCRC Study
Industry Brief - GSK To Create Independent Research Institute In Seattle
Industry Trend Analysis - Genentech's Ocrelizumab Will Be Used In Second-Line MS
Industry Trend Analysis - Biotech Start-Ups To Continue Supporting Big Pharma Pipelines
Industry Trend Analysis - Pfizer's Pristiq Will Need Further Approvals To Become A Blockbuster
Industry Trend Analysis - Biosimilars Will Be Essential In Future RA Treatment Options

Table Of Contents

Key Pharma News 06 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.